MiMedx Group, Inc. (MDXG)
3.21
-0.03
(-0.93%)
USD |
NASDAQ |
Nov 13, 16:00
3.20
-0.01
(-0.31%)
After-Hours: 19:59
MiMedx Group EPS Diluted (Quarterly) : -0.0595 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.0595 |
| June 30, 2026 | -0.1004 |
| March 31, 2026 | -0.0732 |
| December 31, 2025 | 0.1012 |
| September 30, 2025 | 0.1119 |
| June 30, 2025 | 0.0644 |
| March 31, 2025 | 0.0469 |
| December 31, 2024 | 0.0498 |
| September 30, 2024 | 0.0546 |
| June 30, 2024 | 0.1184 |
| March 31, 2024 | 0.0617 |
| December 31, 2023 | 0.3505 |
| September 30, 2023 | 0.0451 |
| June 30, 2023 | -0.0046 |
| March 31, 2023 | -0.0583 |
| December 31, 2022 | -0.0186 |
| September 30, 2022 | -0.089 |
| June 30, 2022 | -0.1107 |
| March 31, 2022 | -0.1082 |
| December 31, 2021 | 0.0055 |
| September 30, 2021 | -0.0353 |
| June 30, 2021 | -0.0297 |
| March 31, 2021 | -0.09 |
| December 31, 2020 | -0.1659 |
| September 30, 2020 | -0.4791 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.0783 |
| March 31, 2020 | -0.0448 |
| December 31, 2019 | -0.0675 |
| September 30, 2019 | 0.113 |
| June 30, 2019 | -0.1609 |
| March 31, 2019 | -0.1247 |
| December 31, 2018 | -0.332 |
| September 30, 2018 | -0.0017 |
| June 30, 2018 | 0.0162 |
| March 31, 2018 | 0.0406 |
| December 31, 2017 | 0.3189 |
| September 30, 2017 | 0.15 |
| June 30, 2017 | 0.07 |
| March 31, 2017 | 0.04 |
| December 31, 2016 | 0.05 |
| September 30, 2016 | 0.03 |
| June 30, 2016 | 0.02 |
| March 31, 2016 | 0.01 |
| December 31, 2015 | 0.12 |
| September 30, 2015 | 0.06 |
| June 30, 2015 | 0.05 |
| March 31, 2015 | 0.04 |
| December 31, 2014 | 0.0356 |
| September 30, 2014 | 0.03 |
| June 30, 2014 | -0.0037 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -0.0232 |
| Perspective Therapeutics, Inc. | -0.2687 |
| T2 Biosystems, Inc. | -- |
| ABVC BioPharma, Inc. | 0.0431 |
| Enovis Corp. | 0.0537 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.683M |
| Revenue (Quarterly) | 62.28M |
| Total Expenses (Quarterly) | 70.97M |
| Enterprise Value | 347.63M |
| Gross Profit Margin (Quarterly) | 79.33% |
| Profit Margin (Quarterly) | -13.94% |
| Earnings Yield | -4.11% |
| Normalized Earnings Yield | -4.109 |